← back to search

Hussein A. Abbas

The University of Texas MD Anderson Cancer Center · US
Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, and CAR-T cell therapy research.
h-index
28
citations
3,464
works
390
NIH funding
primary concept
Medicine
email

Recent publications

Loghavi S, Farhat A, Jamison TJ, El Hajjar G, Bataller A, Wang SA, Wang W, Tang G, Quesada AE, Bazinet A, Cuglievan B, DiNardo CD, Montalban-Bravo G, Takahashi K, Short NJ, Abbas HA , Kadia T, Ravandi F, Daver N, Jabbour E, Borthakur G, Andreeff M, Medeiros LJ, Kantarjian HM, Issa GC . Immunophenoty
2026cited by 0position: selected
Zhu Y, Wang SA, Chien K, Patel KP, Lenskaya V, Medeiros LJ, Abbas HA , Loghavi S . Presumed tumor-infiltrating clonal hematopoiesis unmasking a concomitant systemic mastocytosis with associated myeloid neoplasm in a patient with metastatic melanoma. Virchows Arch, 2026. e-Pub 2026. PMID: 41811504.
2026cited by 0position: selected
Arnuk A, Han C, Lawal AE, Wang B, Karma S, Zhang Z, Yassouf MY, Rajendran SH, Chandok H, Eller ML, Sajedi S, McKenna M, Herman E, Hagen L, Nadorp B, Mo Z, Orellana H, Tsirigos A, Miura P, Abbas HA , Aifantis I, Wang E . Epigenetic reactivation of the tumor suppressor ZBTB7A by KDM4 inhibition in hum
2026cited by 0position: selected
Senapati, J, Croden, J, Garcia-Manero, G, Takahashi, K, Daver, N, Kadia, TM, Borthakur, G, Short, NJ, Jabbour, EJ, Haddad, FG, Marvin-Peek, J, Abbas, HA , Bose, P, Tang, G, Loghavi, S, Shpall, E, Ramdial, JL, Popat, UR, Champlin, RE, Ravandi-Kashani, F, Kantarjian, HM, DiNardo, C . Outcomes of thera
2026cited by 0position: selected
Garcia MB, Wang B, Sheikh I, El Hajjar G, McCall D, Nunez C, Gibson A, Lorenzi PL, Issa GC, Cuglievan B, Abbas HA . High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition. Mol Cell Proteomics 25(3):101522, 2026. e-Pub 2026. PMID: 41621809.
2026cited by 0position: selected
Dasdemir, E, Veletic, I, Ly, C, Quesada, AE, Pacheco, CD, Jelloul, FZ, Borges, P, Basu, S, Jindal, S, Wang, Z, Lazar, A, Wani, K, Antunes, DA, Reville, PK, Gunaratne, PH, Tower, RJ, Sharma, P, Abbas, HA . Integrative spatial multi-omics reveal niche-specific inflammatory signaling and differentiatio
2026cited by 0position: selected
Majid, D, Wang, Z, Schalk, AM, Yuan, B, Tatarata, QZ, Root, J, Garza, AI, Yassouf, MY, Gamal, BT, Feri-Borgogno, S, Nguyen, AH, Konopleva, M, Peeters, E, Su, Y, Reville, PK, Ravandi-Kashani, F, Lavie, A, Abbas, HA . A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinic
2026cited by 0position: selected
Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of <i>JAK2</i>-mutated post-MPN AML
Blood 2025cited by 20position: middledoi
Karrar O, Kantarjian H, Haddad FG, Azevedo RS, Issa G, Ravandi F, Sasaki K, Senapati J, Abbas H, Dellasala S, Jabbour E, Short NJ . Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase. Leuk Lymphoma 66(12):2269-2276, 2025. e-
2025cited by 0position: selected
Han C, Zhang Z, Crosse EI, Sajedi S, Lu B, Wang X, Karma S, Kostich M, Rajendran SH, Udy DB, Chen S, Arnuk A, Lawal AE, Koenig KR, McKenna M, Reville PK, Abbas HA , Abdel-Wahab O, Miura P, Bradley RK, Wang E . An isoform-specific RUNX1C-BTG2 axis governs AML quiescence and chemoresistance. Blood Can
2025cited by 0position: selected
Senapati J, Kantarjian HM, Kadia TM, Kekedjian J, Borthakur G, Daver N, DiNardo CD, Jabbour E, Bose P, Short NJ, Yilmaz M, Jain N, Pemmaraju N, Abbas HA , Issa GC, Maiti A, Bravo GM, Deshmukh I, Shpall E, Kebriaei P, Popat U, Loghavi S, Thakral B, Tang G, Haddad FG, Alvarado Y, Manero GG, Ravandi F
2025cited by 0position: selected
Wang Z, Skwarska A, Poigaialwar G, Chaudhry S, Rodriguez-Meira A, Sui P, Olivier E, Jia Y, Gupta V, Fiskus W, Ramage CL, Zheng G, Schurer A, Gritsman K, Papapetrou EP, Bhalla KN, Zhou D, Mead AJ, Rampal RK, Tyner JW, Abbas HA , Pemmaraju N, Tatarata QZ, Konopleva MY . Efficacy of a Novel BCL-xL Degr
2025cited by 0position: selected
Ly CP, Veletic I, Pacheco CD, Dasdemir E, Jelloul FZ, Ferri-Borgogno S, Basi AV, Gomez JA, Root JL, Reville PK, Jindal S, Basu S, Sharma P, Quesada AE, Bueso-Ramos C, Manshouri T, Cuglievan B, Garcia M, Burks JK, Abbas HA . Multimodal spatial proteomic profiling in acute myeloid leukemia. NPJ Precis
2025cited by 0position: selected
Kugler E, Dasdemir E, Bataller A, Wang B, DiNardo CD, Daver N, Yilmaz M, Short NJ, Borthakur G, Kadia TM, Sasaki K, Hammond D, Bazinet A, Irajizad E, Thakral B, Pierce S, Reville P, Ravandi F, Abbas HA . Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletio
2025cited by 0position: selected
Jen W, Sasaki K, Ravandi F, Kadia TM, Wang SA, Wang W, Loghavi S, Daver NG, DiNardo CD, Issa GC, Abbas HA , Nasnas C, Bataller A, Urrutia S, Karrar OS, Pierce S, Kantarjian HM, Short NJ . Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy.
2025cited by 0position: selected
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
Nature Communications 2024cited by 63position: lastdoi
Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia
Journal for ImmunoTherapy of Cancer 2024cited by 8position: lastdoi
Haddad FG, Sasaki K, Senapati J, Xiao L, Park G, Abuasab T, Venugopal S, Rivera D, Bazinet A, Babakhanlou R, Kim K, Ong F, Desikan S, Pemmaraju N, Loghavi S, Borthakur G, DiNardo C, Abbas HA , Short NJ, Daver N, Jabbour E, Garcia-Manero G, Ravandi F, Kantarjian H, Kadia T . Outcomes of Patients With
2024cited by 0position: selected
Li Z, Li R, Ganan-Gomez I, Abbas HA , Garcia-Manero G, Sun W . Accurate identification of locally aneuploid cells by incorporating cytogenetic information in single cell data analysis. Sci Rep 14(1):24152, 2024. e-Pub 2024. PMID: 39406835.
2024cited by 0position: selected
Bataller A, Kantarjian H, Bazinet A, Kadia T, Daver N, DiNardo CD, Borthakur G, Loghavi S, Patel K, Tang G, Sasaki K, Short NJ, Yilmaz M, Issa GC, Alvarado Y, Montalban-Bravo G, Maiti A, Abbas HA , Takahashi K, Pierce S, Jabbour E, Garcia-Manero G, Ravandi F . Outcomes and genetic dynamics of acute
2024cited by 0position: selected
Narayanan N, Marvin-Peek J, Abouelnaaj MK, Majid D, Wang B, Brown BD, Qiu Y, Kornblau SM, Abbas HA . Reverse Phase Proteomic Array Profiling of Asparagine Synthetase Expression in Newly Diagnosed Acute Myeloid Leukemia. J Proteome Res 23(7):2495-2504, 2024. e-Pub 2024. PMID: 38829961.
2024cited by 0position: selected
Marvin-Peek J, Sasaki K, Kontoyiannis DP, Adachi J, Ohanian M, Takahashi K, Issa GC, Kornblau S, Abbas HA . Nontuberculosis mycobacteria (NTM) infections in patients with leukemia: a single center case series. Front. Med 11, 2024. e-Pub 2024.
2024cited by 0position: selected
Kadia TM, Huang M, Pemmaraju N, Abbas HA , Ly C, Masarova L, Yilmaz M, Lyu MA, Zeng K, Sadeghi T, Cook R, DiNardo CD, Daver N, Issa GC, Jabbour E, Borthakur G, Jain N, Garcia-Manero G, Parmar S, Flowers C, Kantarjian H, Verstovsek S . Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndr
2024cited by 0position: selected
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Nature Medicine 2023cited by 467position: middledoi
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Cancer Immunology Research 2023cited by 29position: lastdoi
IFNγ Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies
Blood 2023cited by 1position: lastdoi
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Nature Medicine 2022cited by 332position: middledoi
Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia
Journal of Clinical Investigation 2022cited by 91position: middledoi
Single Cell RNA-Seq Reveals Intra-Tumoral Heterogeneity Relevant to Differentiation States and Outcomes Among Newly Diagnosed Acute Myeloid Leukemia Patients
Blood 2022cited by 1position: lastdoi
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates
Nature Communications 2016cited by 159position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hussein Abbas · The University of Texas MD Anderson Cancer Center15 papers (None–None)Bofei Wang · Zhengzhou University3 papers (2022–2024)Mark D. Minden · Toronto Public Health2 papers (2022–2022)Dapeng Hao · Harbin Medical University2 papers (2022–2024)Naval Daver · The University of Texas MD Anderson Cancer Center2 papers (2022–2024)Raajit K. Rampal · Icahn School of Medicine at Mount Sinai1 papers (2025–2025)Meyling Cheok · Inserm1 papers (2022–2022)Kapil N. Bhalla · Cancer Clinic1 papers (2025–2025)Weihsu Claire Chen · Amgen (Canada)1 papers (2022–2022)Suraj Bansal · University Health Network1 papers (2022–2022)Shengnan Guo · Harbin Medical University1 papers (2024–2024)Pinpin Sui · The University of Texas at San Antonio1 papers (2025–2025) · 1 papers (2025–2025)Andrea Arruda · Research Canada1 papers (2022–2022)Benjamin Dickins · Pennsylvania State University1 papers (2022–2022)Naveen Pemmaraju · The University of Texas MD Anderson Cancer Center1 papers (2025–2025)John E. Dick · University Health Network1 papers (2022–2022)Zhe Wang · Wenzhou Medical University1 papers (2025–2025)Daohong Zhou · University of Florida1 papers (2025–2025)Tianhao Li · Shanghai Medical College of Fudan University1 papers (2024–2024)